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Abstract
Background: The aims of this study are to evaluate the relationship between early blood glucose concentrations
and mortality and to define a ‘safe range’ of blood glucose concentrations during the first 24 h after pediatric
intensive care unit (PICU) admission with the lowest risk of mortality. We further determine whether associations
exist between PICU mortality and early hyperglycemia and hypoglycemia occurring within 24 h of PICU admission,
even after adjusting for illness severity assessed by the pediatric risk of mortality III (PRISM III) score.
Methods: This retrospective cohort study included patients admitted to PICU between July 2008 and June 2011 in
a tertiary teaching hospital. Both the initial admission glucose values and the mean glucose values over the first
24 h after PICU admission were analyzed.
Results: Of the 1349 children with at least one blood glucose value taken during the first 24 h after admission, 129
died during PICU stay. When analyzing both the initial admission and mean glucose values during the first 24 h
after admission, the mortality rate was compared among children with glucose concentrations ≤65, 65-90, 90–110,
110–140, 140–200, and >200 mg/dL (≤3.6, 3.6–5.0, 5.0–6.1, 6.1–7.8, 7.8–11.1, and >11.1 mmol/L). Children with glucose
concentrations ≤65 mg/dL (3.6 mmol/L) and >200 mg/dL (11.1 mmol/L) had significantly higher mortality rates,
indicating a U-shaped relationship between glucose concentrations and mortality. Blood glucose concentrations of
110–140 mg/dL (6.1–7.8 mmol/L), followed by 90–110 mg/dL (5.0–6.1 mmol/L), were associated with the lowest risk of
mortality, suggesting that a ‘safe range’ for blood glucose concentrations during the first 24 h after admission in
critically ill children exists between 90 and 140 mg/dL (5.0 and 7.8 mmol/L). The odds ratios of early hyperglycemia
(>140 mg/dL [7.8 mmol/L]) and hypoglycemia (≤65 mg/dL [3.6 mmol/L]) being associated with increased risk of
mortality were 4.13 and 15.13, respectively, compared to those with mean glucose concentrations of 110–140 mg/dL
(6.1–7.8 mmol/L) (p <0.001). The association remained significant after adjusting for PRISM III scores (p <0.001).
Conclusions: There was a U-shaped relationship between early blood glucose concentrations and PICU mortality in
critically ill children. Both early hyperglycemia and hypoglycemia were associated with mortality, even after adjusting
for illness severity.
Keywords: Critically ill children, Glucose, Hyperglycemia, Hypoglycemia, Intensive care, Mortality, Pediatric, Pediatric risk
of mortality III
* Correspondence: wj196312@vip.163.com; xing_feng66@yahoo.com.cn
2Institute of Pediatric Research, Suzhou, China
4Department of Neonatology, Children’s Hospital of Soochow University,
215003 Suzhou, China
Full list of author information is available at the end of the article
© 2015 Li et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Li et al. BMC Pediatrics  (2015) 15:88 
DOI 10.1186/s12887-015-0403-y
Background
Both hyperglycemia and hypoglycemia are common
complications of critical illnesses and are significantly
associated with adverse outcomes. This has prompted
clinical societies to recommend glucose control for crit-
ically ill patients [1–10]. However, tight glycemic control
is not a standard practice in the pediatric intensive care
unit (PICU) because of the lack of evidence for overall
benefit and concerns about hypoglycemia [4, 11–14]. A
recently published multicenter, randomized trial showed
that tight glycemic control, with a target blood glucose
range of 4.0 to 7.0 mmol/L (72 to 126 mg/dL), in critic-
ally ill children had no significant effect on major clinical
outcomes. In that study, the incidence of hypoglycemia
was higher with tight glucose control than with conven-
tional glucose control [4]. One may raise a question as
to whether it is possible that tight glycemic control sig-
nificantly increased the risk of hypoglycemia and con-
ferred no overall mortality benefit among critically ill
children. In addition, a previous study conducted in crit-
ically ill adult patients demonstrated that there was a
non-linear U-shaped relationship between mean glucose
levels and ICU mortality in adult patients. Mean glucose
levels <6.7 mmol/L (120 mg/dL) and >8.4 mmol/L
(151 mg/dL) in the medical cohort and mean glucose
levels <7.0 mmol/L (126 mg/dL) and >9.4 mmol/L
(169 mg/dL) in the surgical cohort were associated with
significantly increased ICU mortality. This results in
a ‘safe range’ between approximately 7.0 and
9.0 mmol/L (126 and 162 mg/dL) in the mixed co-
hort of surgical and medical patients [15]. However,
whether these findings apply to critically ill children
remains unclear, and little is known about the level
of the ‘safe range’ in children.
Furthermore, despite the publication of previous stud-
ies that investigated the association of hyperglycemia
and hypoglycemia with mortality in the pediatric popula-
tion [2, 16–23], information on the importance of early
hyperglycemia and hypoglycemia in children is limited
[8, 24, 25]. The association of early hyperglycemia, as
opposed to serial measurements of glucose during the
PICU stay, with mortality in critically ill children is con-
troversial [8, 24, 25].
The aims of this study are to evaluate the relation-
ship between early blood glucose concentrations and
PICU mortality and to define a ‘safe range’ of blood
glucose concentrations during the first 24 h after
PICU admission with the lowest risk of mortality. We
further determine whether associations of PICU mor-
tality with early hyperglycemia and hypoglycemia oc-
curring within 24 h of PICU admission exist even
after adjusting for the severity of illness as assessed
by the score of the pediatric risk of mortality
(PRISM) III in critically ill children.
Methods
Study design
The study was designed as a retrospective cohort ana-
lysis of all children admitted to the PICU during the
period of July 2008 to June 2011. The setting for this
study was a 15-bed PICU with both medical and surgical
patients in a university-affiliated tertiary children’s hos-
pital. The criteria for PICU admission were adopted
from guidelines published by the American Academy of
Pediatrics [26]. We excluded patients with a clinical
diagnosis of diabetes mellitus, patients who did not have
a blood glucose measurement taken during the first 24 h
after admission, and patients who were unexpectedly
discharged or transferred to another hospital. For chil-
dren with multiple PICU admissions within a single hos-
pital stay, only the last admission was included in the
study. The Institutional Review Board of the Children’s
Hospital of Soochow University approved the study. In-
formed consent was not required, because all data were
collected retrospectively.
Clinical and laboratory data
Clinical and laboratory data from the day of admis-
sion were collected and included age, gender, admis-
sion diagnosis, routine hematological tests, a serum
biochemical profile, and an arterial blood gas analysis.
Clinical status, medications given, and therapeutic in-
terventions administered were recorded daily until
PICU discharge or death.
The PRISM III score
The PRISM III score was calculated according to the
methods described in the original studies [27, 28], and in
accordance with our previous study [29].
Clinical outcome
The primary outcome measure was PICU mortality rate,
which was defined as deaths occurring during the PICU
stay. Survivors in the study were discharged to home or
transferred to another department in our hospital.
Glucose parameters and measurements
During the study period, there was no standardized
practice in place for monitoring blood glucose; therefore,
all glucose values were obtained under the discretion of
the treating physicians. All of the children in the study
had at least one blood glucose value measured in the
first 24 h after admission.
Whole blood glucose concentrations were measured
on arterial or venous samples using an automatic bio-
medical blood gas analyzer (CCX, NOVA Biomedical,
Waltham, MA, USA) with a colorimetric assay. System
correlation calibration was performed every 6 months.
The coefficient of variation was 2.8 % at the low level
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and 2.5 % at the high level of blood glucose concentra-
tion. The concentration of blood glucose was expressed
in milligram per deciliter (mg/dL) in the study.
Treatment protocol
Protocolized insulin infusion therapy was not utilized.
Insulin administration and nutritional support route
were determined by the treating physicians.
Data management, interpretation, and analysis
To evaluate the relationship between early blood glucose
concentrations and PICU mortality and to define a ‘safe
range’ for blood glucose concentrations during the first
24 h after PICU admission, both the initial admission
glucose value and the mean glucose value over the first
24 h after PICU admission were analyzed. The initial ad-
mission glucose values and the mean glucose values over
the first 24 h of admission were divided into 6 strata
based on cutoff values of 65, 90, 110, 140, and
200 mg/dL (3.6, 5.0, 6.1, 7.8, and 11.1 mmol/L),
which were established according to clinical observa-
tional and interventional pediatric studies [16, 19, 22].
PICU mortality was calculated for each stratum, and
the stratum with the lowest mortality incidence was
used as a reference.
There are no specific criteria for defining hypergly-
cemia or hypoglycemia in critically ill children. Based on
previous studies conducted in children, hyperglycemia
was defined as a mean blood glucose concentration
>140 mg/dL (7.8 mmol/L) [7, 19], and hypoglycemia was
defined as a mean glucose concentration ≤65 mg/dL
(3.6 mmol/L) [16, 19, 22]. Early hyperglycemia and
hypoglycemia were defined as hyperglycemia and
hypoglycemia occurring within the first 24 h after ad-
mission to the PICU. Glycemic variability was defined as
any patient who had both a hyperglycemic measurement
and a hypoglycemic measurement during the first 24 h
after PICU admission [2].
Statistical analysis
Statistical analyses were performed by using SPSS 13.0.
The data are presented as mean ± SD or median and
interquartile range (IQR), depending on the distribution
of the data. For non-normally distributed variable, the
Mann-Whitney U test was used to compare two groups,
and the Kruskal-Wallis H test was used to determine the
differences among groups.
The glucose values were divided into six strata, and
PICU mortality was calculated for each stratum. The
stratum with the lowest mortality incidence was used as
a reference. The chi-square test or Fisher’s exact test was
used to compare glucose strata. Subsequently, univariate
binary logistic regression analyses were conducted to
calculate the odds ratio (OR) for PICU mortality.
Glucose strata were coded as categorical variables with
the stratum with the lowest risk of mortality used as a
reference. Multivariate binary logistic regression analyses
were performed to investigate whether blood glucose
concentrations were independently associated with PICU
mortality after adjusting for age, gender, and severity of
illness as assessed by the PRISM III score. To determine
whether there was significant collinearity between glu-
cose concentrations and PRISM III scores, collinearity
diagnostics were performed using variance inflation fac-
tor (VIF) and tolerance values. All probability values are
two-sided. Differences with p values <0.05 were consid-
ered to be statistically significant.
Results
Patient characteristics
In total, 1486 children admitted to the PICU during the
study period were eligible for this study. One hundred
and thirty children were excluded: 51 patients who did
not have glucose measurements taken during the first
24 h after PICU admission, 62 who were unexpectedly
discharged due to economic reasons, and 17 who were
transferred to another hospital. Seven children had mul-
tiple PICU admissions within a single hospital stay, only
their last admission was included in the analysis. There-
fore, this study included 1349 critically ill children, in-
cluding 1277 children with a medical admission
diagnosis and 72 with a surgical admission diagnosis.
Admission diagnoses included respiratory diseases
(42.4 %), neurological diseases (22.8 %), gastrointestinal
diseases (7.0 %), trauma or postoperative acute care
(5.4 %), cardiovascular diseases (4.7 %), sepsis (4.0 %),
hematologic/oncologic diseases (3.6 %), poisoning
(2.6 %), and others (7.5 %). Of the 1349 children ana-
lyzed in the study, 129 (9.6 %) died during their PICU
stay. The median time from PICU admission to death
was 48 h (IQR, 24 to 96) after admission.
A total of 2010 blood glucose measurements were ana-
lyzed, including 1665 values from arterial blood samples
and 345 from venous blood samples. The median blood
glucose concentration at admission to the PICU in crit-
ically ill children was 127 mg/dL (7.1 mmol/L) (IQR,
100 to 180 mg/dL [5.6 to 10.0 mmol/L]). Admission glu-
cose concentrations were >140 mg/dL (7.8 mmol/L) in
40.2 %, >180 mg/dL (10.0 mmol/L) in 25.0 %, and
>200 mg/dL (11.1 mmol/L) in 19.3 % of children. How-
ever, only 2.4 % received insulin therapy (0.1u/kg.h) in
the first 24 h after PICU admission to maintain blood
glucose concentration <150 mg/dL (8.3 mmol/L). Ad-
mission glucose concentrations were ≤90 mg/dL
(5.0 mmol/L) in 15.0 % and ≤65 mg/dL (3.6 mmol/L) in
3.6 % of children. Fifteen children (1.1 %) developed gly-
cemic variability during the first 24 h after admission.
Comparisons of demographic and clinical characteristics
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between critically ill children who did and did not sur-
vive are displayed in Table 1.
Relationship between blood glucose at admission and
PICU mortality
The children were divided into 6 strata based on their ad-
mission glucose values. Comparisons of demographic and
clinical characteristics among the strata are displayed in
Table 2. Admission blood glucose ranges for each stratum
and the corresponding PICU mortality rates are displayed
in Fig. 1. The results reveal a U-shaped curve relationship
between glucose concentrations at admission and PICU
mortality in critically ill children. The lowest PICU mor-
tality was observed in the stratum with glucose concentra-
tions of 110–140 mg/dL (6.1–7.8 mmol/L) (3.8 %),
followed by the stratum with glucose concentrations of 90–
110 mg/dL (5.0–6.1 mmol/L) (5.3 %). There was no signifi-
cant difference in the mortality rate between the two strata
(3.8 % vs. 5.3 %, p =0.428). Children in the lowest stratum,
with glucose concentrations ≤65 mg/dL (3.6 mmol/L), and
in the highest stratum, with glucose concentrations
>200 mg/dL (11.1 mmol/L), had significantly higher mor-
tality rates compared to those with glucose concentrations
of 110–140 mg/dL (6.1–7.8 mmol/L) (p <0.001).
Relationship between mean glucose concentrations and
PICU mortality
Of all of the children studied, 47.0 % had two and 2.0 %
had three blood glucose measurements taken in the first
24 h after they were admitted to the PICU. There was
no difference in the median number of glucose measure-
ments during the first 24 h after admission between sur-
viving and non-surviving children (p =0.137).
The mean glucose concentrations during the first 24 h
after PICU admission were analyzed to define a ‘safe
range’ for blood glucose in the first 24 h after admission.
Figure 2 demonstrates the U-shaped curve relationship
between the mean glucose concentrations in the first
24 h after admission and PICU mortality in critically ill
children, showing high mortality in children with mean
glucose concentrations >200 mg/dL (11.1 mmol/L) and
in those with mean glucose concentrations ≤65 mg/dL
(3.6 mmol/L). Additional analyses stratified children by
the severity of their illnesses as assessed by PRISM III
scores in Fig. 3. In both subgroups of children with
PRISM III scores <10 and ≥10, children with mean blood
glucose concentrations >200 mg/dL (11.1 mmol/L) and
children with mean blood glucose concentrations ≤65 mg/
dL (3.6 mmol/L) had significantly increased PICU mortality
rates compared to those with mean blood glucose concen-
trations of 110 to 140 mg/dL (6.1–7.8 mmol/L).
In addition, children with mean glucose concentra-
tions of 90–110 mg/dL (5.0–6.1 mmol/L) (5.1 %) and
110–140 mg/dL (6.1–7.8 mmol/L) (3.9 %) during the
first 24 h after admission had low PICU mortality rates.
Children with mean blood glucose concentrations
≤90 mg/dL (5.0 mmol/L) (14.0 % vs. 3.9 %, p <0.001) and
>140 mg/dL (7.8 mmol/L) (14.2 % vs. 3.9 %, p <0.001) had
significantly increased PICU mortality rates compared to
those with mean blood glucose concentrations of 110 to
140 mg/dL (6.1 to 7.8 mmol/L). These differences
remained significant after adjusting for PRISM III
scores (p <0.05). This results in a ‘safe range’ for
blood glucose concentrations of approximately 90 to
140 mg/dL (5.0–7.8 mmol/L) during the first 24 h
after PICU admission in critically ill children.
Because PRISM III scores include the glucose level
measured in the first 24 h after PICU admission, col-
linearity diagnostics were performed using VIF and
tolerance values before multivariate logistic regression
analysis was performed. VIF and tolerance values of
1.128 and 0.87, respectively, indicate the absence of
significant collinearity between glucose concentrations
and PRISM III scores.
Table 1 Comparison of demographic and clinical characteristics between critically ill children who did and did not survive
Characteristics Survivors (n =1220) Non-survivors (n =129) P value
Age, months 12.0 [3.0–36.0] 11.0 [3.0–36.0] 0.428
Gender, male, n 784 (64.3) 70 (54.3) 0.027
PRISM III score 3 [0–6] 12 [5–24] <0.001
Admission glucose in mg/dL 126 [100–171] 176 [97–374] <0.001
Admission glucose in mmol/L 7.0 [5.6–9.5] 9.8 [5.4–20.8] <0.001
Use of insulina, n 13 (1.1) 20 (15.5) <0.001
Use of steroida, n 583 (47.8) 55 (42.6) 0.308
Mechanical ventilationb, n 205 (16.8) 78 (60.5) <0.001
MODS ≥3c, n 64 (5.2) 61 (47.3) <0.001
Values are median [interquartile range]. Numbers in parentheses denote percentages
MODS multi-organ dysfunction syndrome, PRISM III pediatric risk of mortality III
aAdministration during the first 24 h after PICU admission. bAdministration during PICU stay. cMODS developed during PICU stay
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Association of PICU mortality with early hyperglycemia
and hypoglycemia
Hyperglycemia was prevalent among children in the
PICU; 541 children (40.1 %) were in a hyperglycemic state,
defined as a mean glucose concentration >140 mg/dL
(7.8 mmol/L) in the first 24 h after admission.
Hypoglycemia, defined as a mean blood glucose concen-
tration ≤65 mg/dL (3.6 mmol/L), occurred in 37 (2.7 %) of
the children. A mean blood glucose concentration of 110
to 140 mg/dL (6.1 to 7.8 mmol/L) was used as a reference.
Both early hyperglycemia and hypoglycemia were coded
as a categorical variable and were significantly associated
with PICU mortality in a univariate binary logistic regres-
sion analysis.
The OR for early hyperglycemia being associated with
an increased risk of mortality was 4.13 (95 % CI, 2.30–
7.41; p <0.001). The association remained significant
after adjusting for age, gender, and PRISM III scores
using a multivariate binary logistic regression analysis
(OR =2.06; 95 % CI, 1.07–3.96; p =0.031). We further
evaluated the association between severe and mild
hyperglycemia and PICU mortality. A mean blood glu-
cose concentration >200 mg/dL (11.1 mmol/L) was con-
sidered as severe hyperglycemia, and a level of 140–
200 mg/dL (7.8–11.1 mmol/L) as mild hyperglycemia.
As reported in Table 3, both severe and mild hypergly-
cemia were associated with increased PICU mortality
compared to mean blood glucose concentrations of 110
to 140 mg/dL (6.1–7.8 mmol/L). However, only severe
hyperglycemia remained associated with PICU mortality
after adjusting for age, gender, and PRISM III scores
(OR =2.25; 95 % CI, 1.17–4.36; p =0.016).
The OR for PICU mortality being associated with
hypoglycemia was 15.13 (95 % CI, 6.45–35.49; p <0.001)
compared to those with mean blood glucose concentra-
tions of 110 to 140 mg/dL (6.1–7.8 mmol/L). The asso-
ciation remained significant after adjusting for age,
gender, and PRISM III scores using a multivariate binary
logistic regression analysis (OR =12.68; 95 % CI, 4.48–
35.88; p <0.001).
Table 2 Comparison of demographic and clinical characteristics among children with different values of admission blood glucose
Blood glucose, mg/dL (mmol/L) ≤65 (≤3.6) 65–90 (3.6–5.0) 90–110 (5.0–6.1) 110–140 (6.1–7.8) 140–200 (7.8–11.1) >200 (>11.1) P value
N 48 (3.6) 155 (11.5) 262 (19.4) 342 (25.4) 281 (20.8) 261 (19.3)
Age, months 8.0 [2.0–30.0] 8.0 [2.0–24.0] 11.5 [3.0–37.5] 9.0 [3.0–32.3] 12.0 [5.0–48.0] 12.0 [4.0–36.0] 0.002
Gender, male, n 27 (56.3) 103 (66.5) 179 (68.3) 225 (65.8) 179 (63.7) 141 (54.0) 0.013
PRISM III score 5 [2–12] 2 [0–5] 2 [0–5] 3 [0–6] 3 [0–6] 7 [4–14] <0.001
Mechanical ventilationa, n 14 (29.8) 20 (12.8) 30 (11.5) 54 (15.8) 60 (21.4) 95 (36.4) <0.001
MODS ≥3b, n 13 (27.7) 9 (5.8) 7 (2.7) 20 (5.8) 16 (5.7) 60 (23.0) <0.001
PICU mortality, n 16 (34.0) 10 (6.4) 14 (5.3) 13 (3.8) 16 (5.7) 60 (23.0) 0.003
Values are median [interquartile range]. Numbers in parentheses denote percentages
MODS multi-organ dysfunction syndrome, PRISM III pediatric risk of mortality III
aAdministration during PICU stay. bMODS developed during PICU stay
Figure 1 PICU Mortality rates according to different admission glucose cutoff values. PICU, pediatric intensive care unit. Curve represents a
polynomial trendline. p value: comparison to children with admission blood glucose of 110 to 140 mg/dL (6.1 to 7.8 mmol/L). **p <0.01.
Probability values: Chi-square test
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Association of PICU mortality with early hyperglycemia
and hypoglycemia, stratified by illness severity
The association of PICU mortality with both early hyper-
glycemia (>140 mg/dL [7.8 mmol/L]) and hypoglycemia
(≤65 mg/dL [3.6 mmol/L]) remained significant after
adjusting for illness severities as assessed by PRISM III
scores (hyperglycemia: OR =2.13; 95 % CI, 1.11–4.10;
p =0.023; hypoglycemia: OR =12.01; 95 % CI, 4.42–
32.62; p <0.001).
In addition, as displayed in Table 4, severe hypergly-
cemia (>200 mg/dL [11.1 mmol/L]) and hypoglycemia
(≤65 mg/dL [3.6 mmol/L]) were consistently associated
with an increased risk of PICU mortality in both sub-
groups of children with PRISM III scores <10 and ≥10.
Discussion
This study provides data on early blood glucose concen-
trations in critically ill children and demonstrates that
there is a U-shaped relationship between blood glucose
concentrations measured during the first 24 h after
PICU admission and PICU mortality. Blood glucose con-
centrations of 110–140 mg/dL (6.1–7.8 mmol/L),
followed by 90–110 mg/dL (5.0–6.1 mmol/L), were asso-
ciated with the lowest OR for mortality, suggesting that
Figure 2 PICU Mortality rates according to different mean glucose cutoff values. PICU, pediatric intensive care unit. Curve represents a polynomial
trendline. p value: comparison to children with mean blood glucose of 110 to 140 mg/dL (6.1 to 7.8 mmol/L). *p <0.05, **p <0.01. Probability
values: Chi-square test
Figure 3 PICU Mortality rates according to different mean glucose cutoff values, stratified by PRISM III score. PICU, pediatric intensive care unit;
PRISM III, pediatric risk of mortality III. p value: comparison to children with mean blood glucose of 110 to 140 mg/dL (6.1 to 7.8 mmol/L).
**p <0.01. Probability values: Chi-square test or Fisher’s exact test
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a ‘safe range’ for blood glucose concentrations exists be-
tween 90 and 140 mg/dL in the first 24 h after PICU ad-
mission in critically ill children.
The U-shaped relationship between blood glucose
concentrations at admission and PICU mortality, with
increased mortality in the lower and upper levels in this
study, is in line with recently published findings con-
ducted on critically ill adult patients [15]. The optimal
glucose concentrations in our study are somewhat lower
than the results from the cohort of adult patients. This
is possibly due to differences between children and
adults. The normal range of blood glucose level associ-
ated with reduced morbidity and mortality decreases
with age in non-neonatal children [30]. Another differ-
ence is the low percentage of our patients admitted with
a surgical diagnosis.
The other major findings in this study were that both
early hyperglycemia and hypoglycemia occurring within
24 h of PICU admission were associated with increased
PICU mortality rates, even after adjusting for age, gen-
der and illness severity in this population of critically ill
children. Numerous studies have demonstrated that
hyperglycemia is associated with increased mortality
rates in children [2, 16–18, 23]. To our knowledge, a
limited number of studies verified the use of early hyper-
glycemia as a prognostic predictor in critically ill chil-
dren [8, 24, 25]. Our results are in agreement with a
study by Faustino, who reported that the relative mortal-
ity risk increased for PICU patients with glucose concen-
trations >150 mg/dL (8.3 mmol/L) in the first 24 h after
admission [8].
The discrepancy between our data and the data from
another study performed in children admitted to the
PICU can most likely be attributed to the difference in
the cutoff value for defining hyperglycemia [25]. Our
study showed that hyperglycemia, defined as a blood
glucose concentration >140 mg/dL (7.8 mmol/L), was
significantly associated with a higher PICU mortality
rate. However, In the previous study, they used a blood
glucose concentration of 200 mg/dL (11.1 mmol/L) as
the threshold for differentiating high glucose concentra-
tions from normal glucose concentrations, and con-
cluded that hyperglycemia within 24 h of PICU
admission was not independently associated with in-
creased mortality. The normal glucose (<200 mg/dL
Table 3 Association of PICU mortality with early hyperglycemia
and hypoglycemia: comparison to children with mean blood
glucose of 110 to 140 mg/dL*
Mean Glucose, mg/dL (mmol/L) ORa 95 % CI P value
>200 (11.1)a 7.86 4.21–14.66 <0.001d
140–200 (7.8–11.1)b 2.25 1.17–4.36 0.016e
110–140 (6.1–7.8) 1 N.A.
90–110 (5.0–6.1) 1.37 0.64–2.92 0.416
65–90 (3.6–5.0) 1.90 0.82–4.38 0.133
≤65 (3.6)c 15.13 6.45–35.49 <0.001d
*The mean glucose concentration of the first 24 h of admission >140 mg/dL
was defined as early hyperglycemia; mean glucose concentration ≤65 mg/dL
was defined as early hypoglycemia
Glucose strata were coded as a categorical variable with the mean glucose
concentration of 110–140 mg/dL as a reference
CI confidence interval, OR odds ratio, PICU pediatric intensive care unit
asevere hyperglycemia. bmild hyperglycemia. chypoglycemia. dThe association
remained significant after adjusting for age, gender, and PRISM III scores. eThe
association did not remain significant after adjusting for age, gender, and
PRISM III scores
Table 4 Association of PICU mortality with early hyperglycemia and hypoglycemia, stratified by PRISM III score: comparison to
children with mean blood glucose of 110 to 140 mg/dL*
Mean glucose, mg/dL (mmol/L) OR 95 % CI P value
PRISM III <10 >200 (11.1)a 4.17 1.58–11.02 0.005
140–200 (7.8–11.1)b 2.13 0.84–5.43 0.115
110–140 (6.1–7.8) 1 N.A.
90–110 (5.0–6.1) 1.48 0.53–4.14 0.599
60–90 (3.6–5.0) 1.80 0.56–5.79 0.338
≤65 (3.6)c 14.67 4.46–48.19 <0.001
PRISM III ≥10 >200 (11.1)a 5.14 2.04–12.98 <0.001
140–200 (7.8–11.1)b 2.05 0.75–5.66 0.217
110–140 (6.1–7.8) 1 N.A.
90–110 (5.0–6.1) 1.36 0.35–5.29 0.725
60–90 (3.6–5.0) 3.02 0.78–11.73 0.133
≤65 (3.6)c 8.69 2.19–34.45 0.002
*The mean glucose concentration of the first 24 h of admission >140 mg/dL was defined as early hyperglycemia; mean glucose concentration ≤65 mg/dL was
defined as early hypoglycemia
Glucose strata were coded as a categorical variable with the mean glucose concentration of 110–140 mg/dL as a reference
CI confidence interval, OR odds ratio, PICU pediatric intensive care unit, PRISM III pediatric risk of mortality III
asevere hyperglycemia. bmild hyperglycemia. chypoglycemia
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[11.1 mmol/L]) group included patients with glucose
concentrations of 60–200 mg/dL (3.3–11.1 mmol/L)
[25]. It is possible that blood glucose concentrations be-
tween 60 and 90 mg/dL (3.3 and 5.0 mmol/L) or be-
tween 140 and 200 mg/dL (7.8 and 11.1 mmol/L) in
children could significantly increase their risk of mortal-
ity and confer no advantage.
In the present study, 2.7 % of the patients had mean
glucose concentrations ≤65 mg/dL (3.6 mmol/L) in the
first 24 h after PICU admission. It is well known that the
developing brains of children, especially infants, are
more vulnerable to hypoglycemia [13, 22]. The imple-
mentation of tight glucose control is often tempered by
concerns of inducing hypoglycemia [11, 13, 31, 32]. The
definition of hypoglycemia is not consistent and varies
in clinical practice for non-diabetic children [22]. Most
have defined hypoglycemia as blood glucose concentra-
tions <40 or <60–65 mg/dL (<2.2 or <3.3–3.6 mmol/L),
while some have reported a definition of glucose con-
centrations <80 mg/dL (4.4 mmol/L) [16, 20–22, 33]. Al-
though a few studies have concluded, based on point-of-
care glucose measurements during PICU stays, that
hypoglycemia is associated with increased mortality in
critically ill children [16, 20–22], we were first to dem-
onstrate that hypoglycemia occurring within 24 h of
PICU admission was significantly associated with higher
PICU mortality rates. Moreover, the association was in-
dependent of age, gender, and illness severity as assessed
by PRISM III scores.
Our study has several limitations. The first is the
weakness that is inherent in retrospective studies.
There was no standard technique or protocol for
collecting or analyzing blood glucose samples. Sec-
ond, both arterial and venous whole blood glucose
concentrations were analyzed in this study. It has
been found that there were no differences between
median arterial (161 mg/dL [8.9 mmol/L]) and ven-
ous (162 mg/dL [9.0 mmol/L]) whole blood glucose
concentrations in critical ill patients after cardiac
surgery, which suggests that venous blood may be a
good alternative to arterial blood for glucose mea-
surements [34]. However, differences between glu-
cose values drawn via different sample sites should
be considered. Third, our findings may not be
generalizable to critically ill children receiving ag-
gressive glucose control. In our study, 25 % of the
patients had an initial blood glucose concentration
>180 mg/dL (10.0 mmol/L); however, only 2.4 % re-
ceived insulin therapy in the first 24 h after they
were admitted to the PICU. Further multicenter
studies will be needed to confirm our findings and
improve the generalizability of these results. Finally,
we were unable to include data regarding medica-
tions or nutrition in the analysis to assess their
effect on the relationship between blood glucose
concentrations and mortality, as we did not have in-
formation concerning these data for all of the pa-
tients during their transfers to the PICU.
Conclusions
Our study indicates that there is a U-shaped rela-
tionship between early blood glucose concentrations
and PICU mortality. Blood glucose concentrations of
110–140 mg/dL (6.1–7.8 mmol/L), followed by 90–
110 mg/dL (5.0–6.1 mmol/L), were associated with
the lowest OR for mortality, suggesting a ‘safe range’
of blood glucose concentrations of between 90 and
140 mg/dL (5.0–7.8 mmol/L) in the first 24 h after
PICU admission in critically ill children. Both early
hyperglycemia and hypoglycemia occurring within
24 h of PICU admission were significantly associated
with mortality in critically ill children, even after
adjusting for age, gender, and illness severity. Further
studies are necessary to define the ‘safe range’ in
randomized prospective clinical trials.
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